As of Sep 23
| -0.26 / -0.32%|
The 2 analysts offering 12-month price forecasts for Cantel Medical Corp have a median target of 74.00, with a high estimate of 83.00 and a low estimate of 65.00. The median estimate represents a -8.79% decrease from the last price of 81.13.
The current consensus among 3 polled investment analysts is to Hold stock in Cantel Medical Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.